Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
July 2012, Vol 5, No 4
Practice Management
Emerging Trends in Cancer Care: Health Plans’ and Pharmacy Benefit Managers’ Perspectives on Changing Care Models
Rhonda Greenapple, MSPH
,
Gary M. Owens, MD
Read More
Original Research
Chemotherapy-Induced Nausea and Vomiting: Optimizing Prevention and Management
Kamakshi V. Rao, PharmD, BCOP, CPP
,
Aimee Faso, PharmD, BCOP, CPP
Stakeholder Perspective
Selecting Best Therapies for Control of Chemotherapy-Induced Nausea and Vomiting
Read More
Original Research
Diabetes Medications and Cancer Risk: Review of the Literature
Lindsay Sanders, DO, MPH
,
Anu P. Michael, MD
,
Scott R. Anderson, MS IV
,
Loida D. Nguyen, PharmD, BCPS
,
Zackary A. Johnson, MS II
,
Quang T. Nguyen, DO, FACE, FTOS
Stakeholder Perspective
Cancer Risk Associated with Antidiabetes Medications: Implications for Patients, Providers, and Payers
by
Matthew Mitchell, PharmD, MBA, FAMCP
Read More
Introduction
Cancer: Exploding Treatment and Diagnostic Pipeline, and Ever-Increasing Costs
Craig K. Deligdish, MD
Read More
Results 1 - 4 of 4